References
- BELPAIRE, M. F., DE SMET, F., CHINDAVIJAK, B., FRAEYMAN, N. and BOGAERT, G. M., 1989, Effect of turpentine-induced inflammation on the disposition kinetics of propranolol, metoprolol and antipyrine in the rat. Fundamentals in Clinical Pharmacology, 3, 79–88.
- BISHOP, H., SCHNEIDER, E. R. and WELLING, P., 1981, Plasma propranolol concentrations in rats with adjuvant-induced arthritis. Biopharmacology and Drug Disposition, 2, 291–297.
- BOOTH, L. C., BROUWER, R. K. and BROUWER, L. R. K., 1998, Effect of multidrug resistance modulators on the hepatobiliary disposition of doxorubicin in the isolated perfused rat liver. Cancer Research, 58, 3641–3648.
- BUCHAR, E. and JANKU, I., 1985, The effect of adjuvant-induced arthritis on rat liver microsomal phospholipid metabolism. Methods and Findings in Experimental and Clinical Pharmacology, 7, 469–472.
- DIPASQUALE, G., WELAJ, P. and RASSAERT, L. C., 1974, Prolonged pentobarbital sleeping time in adjuvant-induced polyarthritic rats. Research Communications in Chemical Pathology and Pharmacology, 9, 253–264.
- HARRIS, E. D., 1981, Rheumatoid arthritis; the clinical spectrum. In Textbook of Rheumatology (Philadelphia: W. B. Saunders), pp. 928–963.
- HE, L. Y., TANIGAWARA, Y., YASUHARA, M. and HORI, R., 1991, Effect of folinic acid On tissue residence and excretion of methotrexate in rats. Drug Metabolism and Disposition, 19, 729–734.
- HONSCHA, W. and PETZINGER, E., 1999, Characterization of the bile acid sensitive methotrexate carrier of rat liver cells. Naunyn-Schmiedeberg's Archives in Pharmacology, 359, 411–419.
- LIN, J. H., SUGIYAMA, Y., AWAZU, S. and HANANO, M., 1982, In vitro and in vivo evaluation of the tissue-to-blood partition coefficient for physiological pharmacokinetic models. Journal in Pharmacokinetics and Biopharmacology, 10, 637–647.
- MASUDA, M., PIZUKA, Y., YAMAZAKI, M., NISHIGAKI, R., KATO, Y., NeINUMA, K., SUZUKI, H. and SUGIYAMA, Y., 1997, Methotrexate is excreted into the bile by canalicular multispecific organic anion transporter in rats. Cancer Research, 57, 3506–3510.
- MEUNIER, J. C. and VERBEECK, K. R., 1999, Glucuronidation of R- and S-ketoprofen, acetoaminophen, and diflunisal by liver microsomes of adjuvant-induced arthritic rats. Drug Metabolism and Disposition, 27, 26–31.
- MURATA, M., TAMAI, I., SAL, Y., NAGATA, O., KATO, H., SUGIYAMA, Y. and TSUJI, A., 1998, Hepatobiliary transport kinetics of HSR-903, a new quinolone antibacterial agent. Drug Metabolism and Disposition, 26, 1113–1119.
- NAKAMURA, J., NISHIDA, T., HAYASHI, K., KAWADA, N., UESHIMA, S., SUGIYAMA, Y., ITo, T., SOBUE, K. and MATSUDA, H., 1999, Kupffer cell-mediated down regulation of rat hepatic CMOAT/MRP2 gene expression. Biochemistry and Biophysics Research Communications, 255, 143–149.
- PHILIPPE, L., GEGOUT-POTTIE, P., GUINGAMP, C., BORDJI, K., TERLAIN, B., NETTER, P. and GILLET, P., 1997, Relations between functional, inflammatory, and degenerative parameters during adjuvant arthritis in rats. American journal of Physiology, 273, R1550—R1556.
- PIQUETTE-MILLER, M. and JAMALI, F. 1992, Effect of adjuvant arthritis on the disposition of acebutolol enantiomer in rats. Agent Actions, 37, 290–296.
- PIQUETTE-MILLER, M. and JAMALI, F., 1993, Selective effect of adjuvant arthritis on the disposition of propranolol enantiomer in rats detected using a stereospecific HPLC assay. Pharmaceutical Research, 19, 294–299.
- SCHNEIDER, R. E., BISHOP, H. and HAWKINS, C. F., 1979, Plasma propranolol concentrations and the erythrocyte sedimentation rate. British journal of Clinical Pharmacology, 8, 43–47.
- SHIBATA, N., SHIMAKAWA, H., MINOUCHI, T. and YAMAJI, A., 1993, Pharmacokinetics of cyclosporin A after intravenous administration to rats in various disease states. Biological and Pharmacological Bulletin, 16, 1130–1135.
- TODA, A., Isfm, N., KIHARA, T., NAGAMATSU, A. and SHIMENO, H., 1994, Effects of adjuvant-induced arthritis on hepatic drug metabolism in rats. Xenobiotica, 24, 603–611.
- TODA, A., KIHARA, T., ONO, N., NAGAMASU, A. and SHIMENO, H., 1996, Liver haem metabolism in adjuvant-induced arthritis rats. Xenobiotica, 26, 415–423.
- TRACY, T. S., WORSTER, T., BRADLEY, J. D., GREENE, P. K. and BRATER, D. C., 1994, Methotrexate disposition following concomitant administration of ketoprofen, piroxicam and flurbiprofen in patients with rheumatoid arthritis. British Journal of Clinical Pharmacology, 37,453–456.
- VOS, T. A., HOOIVED, G. J. E., KONING, H., CHILDS, S., MEIJER, D. K. F., MOSHAGE, H., JANSEN, P. L. M. and MULLER, M., 1998, Up-regulation of the multidrug resistance genes, mrpl and mdrlb, and down-regulation of the organic anion transporter, mrp2, and the bile salt transporter, spgp, in endotoxemic rat liver. Hepatology, 28, 1637–1644.
- WILLIAMS, R. O., FELDMANN, M. and MAINI, N. R., 1992, Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. Proceedings of the National Academy of Sciences, USA, 89, 9784–9788.
- YASUHARA, M., FUJIWARA, J., KITADE, S., KATAYAMA, H., OKUMURA, K. and HORI, R., 1985, Effect of altered plasma protein on pharmacokinetics and pharmacodynamics of propranolol in rats after surgery. Journal of Pharmacology and Experimental Therapeutics, 235,513–520.